The use of high doses of oxycodone in an acute palliative care unit

American Journal of Hospice and Palliative Medicine

Volumn 28, Issue 4, 2011, Pages 242-244

  Mercadante, Sebastiano ^a   Ferrera, Patrizia ^a   David, Fabrizio ^a   Casuccio, Alessandra ^b  

^a LA MADDALENA CANCER CENTER   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

adverse effects; cancer pain; opioids; oxycodone; palliative care; supportive care

Indexed keywords

NARCOTIC ANALGESIC AGENT; OXYCODONE;

ACUTE DISEASE; AGE; AGED; ARTICLE; DELAYED RELEASE FORMULATION; DOSE RESPONSE; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; PAIN; PALLIATIVE THERAPY; RETROSPECTIVE STUDY;

ACUTE DISEASE; AGE FACTORS; AGED; ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OXYCODONE; PAIN; PALLIATIVE CARE; RETROSPECTIVE STUDIES;

EID: 79958210063     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909110381378     Document Type: Article

References (16)

1. Hanks GW, Conno F., Cherny N.,et al,Expert Working Group of the Research Network of the European Association for Palliative Care. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84(5):587-593.
2. Radbruch L., Grond S., Zech D., Bischoff A. High-dose oral morphine in cancer pain management: a report of twelve cases. J Clin Anesth. 1996;8(2):144-150.
3. Bercovitch M., Adunsky A. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it? Cancer. 2004;101(6):1473-1477.
4. Bercovitch M., Waller A., Adunsky A. High dose morphine use in the hospice setting. A database survey of patient characteristics and effect on life expectancy. Cancer. 1999;86(5):871-877.
5. Glare P., Walsh D. Dose-ranging study of oxycodone for chronic pain in advanced cancer. J Clin Oncol. 1993;11(5):973-978.
6. Reid CM, Martin RM, Sterne JA, Davies AN, Hanks GW Oxycodone for cancer-related pain:meta-analysis of randomized controlled trias. Arch Intern Med. 2006;166(8):837-843.
7. Bercovitch M., Adunsky A. High dose controlled-release oxycodone in hospice care. J Pain Palliat Care Pharm.2006;20(4): 33-39.
8. Riley J., Ross JR, Rutter D.,et al.No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer. 2006;14(1):56-64.
9. Silvestri B., Bandieri E., Del prete S.,et al.Oxycodone controlled-release as first choice therapy for moderate-to-severe cancer pain in Italian patients. Clin Drug Investig. 2008;28(7):399-407.
10. Citron M., Kaplan R., Parris W.,et al.Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain. Cancer Investig. 1998;16(8):562-571.
11. Ferrarese F., Becchimanzi G., Bernardo M.,et al.Pain treatment with high dose, controlled release oxycodone: an Italian perspective. Ther Clin Risk Manage. 2008;4(4):665-671.
12. Viganó A., Bruera E., Suarez-Almazor ME Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer. 1998;83(6):1244-1250.
13. Kalso E. Oxycodone. J Pain Symptom Manage. 2005;29(5suppl): S47-S56.
14. Mercadante S., Arcuri E. Pharmacological management of cancer pain in the elderly. Drugs Aging. 2007;24(9):761-776.
15. Núñez Olarte JM Oxycodone and the challenge of neuropathic cancer pain: a review. Oncology. 2008;74(suppl1):83-90.
16. Mercadante S., Villari P., Ferrera P., Casuccio A. Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol. 2005;23(22):5229-5234.